Didar Khassenov
Didar Khassenov has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Azat Chinaliyev
Center of Interventional Radiology, National Research Oncology Center
3 shared publications - Tokan Sultanaliev
Национальный научный онкологический центр, Центр сосудистой хирургии, г. Нур-Султан, Республика Казахстан
2 shared publications - Zhandos Burkitbayev
National Research Oncology Center
2 shared publications - Aida Shakirova
Women’s Health Department, National Research Oncology Center, Astana 010000, Kazakhstan
1 shared publication Aktolkyn Daumen
Interventional Radiologist. Department of Expert Endoscopy and Interventional Radiology, National Research Oncology Center LLP, Astana, Kazakhstan
1 shared publication- Amankeldi A. Salybekov
Kidney Disease and Transplant Center, Shonan Kamakura General Hospital
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (18) , 2902
Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic Strategies—A Systematic Review
Background/Objectives: Molecular classification has reshaped risk assessment in endometrial cancer (EC), but the strength and clinical applicability of the evidence vary across molecular subgroups, assay platforms, patient populations, and treatment settings. This systematic review critically evaluated the prognostic and predictive value of TCGA-derived classifiers, additional biomarkers, multiple-classifier tumors, and molecularly informed therapeutic strategies. Methods: A protocol was developed a priori but was not prospectively registered. PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library were searched for primary studies published from January 2013 through June 2026. Clinical guidelines were used only to provide clinical context and were not included in the formal evidence set. Because of substantial methodological heterogeneity, findings were synthesized narratively by study design and clinical question. Risk of bias was assessed using QUADAS-2, the Newcastle–Ottawa Scale, and RoB 2. Results: Seventy-four studies involving approximately 42,000 patients were included. POLE-mutated tumors showed the most favorable outcomes in most cohorts, whereas p53-abnormal tumors, defined by abnormal immunohistochemical patterns, generally had the poorest prognosis. Mismatch repair deficiency identified by immunohistochemistry and microsatellite instability-high status identified by PCR- or NGS-based testing were highly related but analytically distinct biomarkers and were not treated as exact synonyms. The NSMP group remained heterogeneous; integrated assessment of estrogen/progesterone receptor expression, CTNNB1, L1CAM, ARID1A, and chromosome 1q alterations may improve risk discrimination, although most of these markers remain investigational. In multiple-classifier tumors, available data support a practical hierarchy in which a pathogenic POLE mutation generally takes precedence, followed by MMR deficiency and then p53 abnormality. Across studies, molecular classification usually added prognostic information to clinicopathologic assessment, but the magnitude of benefit varied, and no overall certainty rating was assigned. Conclusions: Molecular classification is incorporated into contemporary guidelines and can support prognostic assessment and treatment selection when interpreted together with stage, histology, and other clinicopathologic factors. The strongest current clinical utility relates to POLE, MMR/MSI, p53 immunohistochemistry, and HER2 in selected settings; additional NSMP and multi-omics biomarkers require prospective validation, assay standardization, and demonstration of clinical utility before routine adoption.
- 9 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (18) , 2902
Open AccessMolecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic Strategies—A Systematic Review
Background/Objectives: Molecular classification has reshaped risk assessment in endometrial cancer (EC), but the strength and clinical applicability of the evidence vary across molecular subgroups, assay platforms, patient populations, and treatment settings. This systematic review critically evaluated the prognostic and predictive value of TCGA-derived classifiers, additional biomarkers, multiple-classifier tumors, and molecularly informed therapeutic strategies. Methods: A protocol was developed a priori but was not prospectively registered. PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library were searched for primary studies published from January 2013 through June 2026. Clinical guidelines were used only to provide clinical context and were not included in the formal evidence set. Because of substantial methodological heterogeneity, findings were synthesized narratively by study design and clinical question. Risk of bias was assessed using QUADAS-2, the Newcastle–Ottawa Scale, and RoB 2. Results: Seventy-four studies involving approximately 42,000 patients were included. POLE-mutated tumors showed the most favorable outcomes in most cohorts, whereas p53-abnormal tumors, defined by abnormal immunohistochemical patterns, generally had the poorest prognosis. Mismatch repair deficiency identified by immunohistochemistry and microsatellite instability-high status identified by PCR- or NGS-based testing were highly related but analytically distinct biomarkers and were not treated as exact synonyms. The NSMP group remained heterogeneous; integrated assessment of estrogen/progesterone receptor expression, CTNNB1, L1CAM, ARID1A, and chromosome 1q alterations may improve risk discrimination, although most of these markers remain investigational. In multiple-classifier tumors, available data support a practical hierarchy in which a pathogenic POLE mutation generally takes precedence, followed by MMR deficiency and then p53 abnormality. Across studies, molecular classification usually added prognostic information to clinicopathologic assessment, but the magnitude of benefit varied, and no overall certainty rating was assigned. Conclusions: Molecular classification is incorporated into contemporary guidelines and can support prognostic assessment and treatment selection when interpreted together with stage, histology, and other clinicopathologic factors. The strongest current clinical utility relates to POLE, MMR/MSI, p53 immunohistochemistry, and HER2 in selected settings; additional NSMP and multi-omics biomarkers require prospective validation, assay standardization, and demonstration of clinical utility before routine adoption.
- Open Access
- 14 January 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (1) , onmt014
Combined Methods for Biliary Stricture Management: A Case Series
Biliary strictures represent one of the most common complications after liver transplantation, occurring in 10-30% of recipients and significantly affecting patient quality of life and graft function. Combined hybrid approaches are increasingly widespread in contemporary practice. Objective: To present a case series of successful application of combined methods for biliary stricture management in patients after liver transplantation and to analyze the efficacy and safety of these approaches. Methods: A prospective observational study of three female patients (median age 57.0±7.8 years) after orthotopic liver transplantation with biliary strictures was conducted. All underwent a combined procedure using the rendezvous technique, integrating percutaneous transhepatic and endoscopic approaches with biliary stent placement. Results: Technical success was achieved in 100% of cases (3/3). Clinical success with bilirubin reduction >50% was registered in all patients (3/3, 100%). Total bilirubin decreased from 71.3±22.8 μmol/L to 58.2±18.5 μmol/L by day 7 and to 32.4±8.6 μmol/L by day 30. No serious complications were registered (0/3, 0%). Mean hospitalization was 5.3±1.5 days (range 4-7 days). Mean procedure duration was 85±15 minutes. Conclusion: The combined method demonstrated high technical feasibility (100%), clinical efficacy (100%), and a favorable safety profile with no serious complications, showing particular effectiveness in recurrent strictures. This approach can be considered as a promising alternative to isolated interventions in treating complex anastomotic biliary strictures.
- 14 January 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (1) , onmt014
Open AccessCombined Methods for Biliary Stricture Management: A Case Series
Biliary strictures represent one of the most common complications after liver transplantation, occurring in 10-30% of recipients and significantly affecting patient quality of life and graft function. Combined hybrid approaches are increasingly widespread in contemporary practice. Objective: To present a case series of successful application of combined methods for biliary stricture management in patients after liver transplantation and to analyze the efficacy and safety of these approaches. Methods: A prospective observational study of three female patients (median age 57.0±7.8 years) after orthotopic liver transplantation with biliary strictures was conducted. All underwent a combined procedure using the rendezvous technique, integrating percutaneous transhepatic and endoscopic approaches with biliary stent placement. Results: Technical success was achieved in 100% of cases (3/3). Clinical success with bilirubin reduction >50% was registered in all patients (3/3, 100%). Total bilirubin decreased from 71.3±22.8 μmol/L to 58.2±18.5 μmol/L by day 7 and to 32.4±8.6 μmol/L by day 30. No serious complications were registered (0/3, 0%). Mean hospitalization was 5.3±1.5 days (range 4-7 days). Mean procedure duration was 85±15 minutes. Conclusion: The combined method demonstrated high technical feasibility (100%), clinical efficacy (100%), and a favorable safety profile with no serious complications, showing particular effectiveness in recurrent strictures. This approach can be considered as a promising alternative to isolated interventions in treating complex anastomotic biliary strictures.
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 52 (2)
EFFECTIVENESS OF A MULTIMODAL PATIENT EDUCATION PROGRAM IN PATIENTS WITH AND WITHOUT TROPHIC ULCERS OF THE LOWER EXTREMITIES ASSOCIATED WITH PERIPHERAL ARTERY DISEASE
Relevance. Chronic limb-threatening ischemia is the most severe manifestation of peripheral artery disease, carrying high rates of amputation and mortality. Structured patient education programs have demonstrated benefit in other chronic diseases, yet remain largely unevaluated in peripheral artery disease, particularly chronic limb-threatening ischemia. Objective. To evaluate the effectiveness of a structured multimodal educational program (CLTI School) compared with standard care on clinical outcomes and quality of life in patients with peripheral artery disease. Materials and Methods. Parallel-group randomized controlled trial conducted in Astana, Kazakhstan. A total of 184 patients with peripheral artery disease (Rutherford categories 2-5) were randomized 1:1 and followed for 12 months. The program comprised eight vascular surgeon-led group sessions, a digital platform, peer support groups, and smoking cessation counseling. Per-protocol analysis included 81 experimental and 78 control participants. Co-primary outcomes were health-related quality of life (SF-12) and peripheral artery disease -related hospitalization rate. Results. At 12 months, the experimental group showed significantly higher SF-12 Physical Component Summary (44.76 vs. 35.08; p < 0.001) and Mental Component Summary (43.42 vs. 35.90; p < 0.001) scores. Hospitalizations (14.8 % vs. 20.5 %; p = 0.346) and amputations (4.9 % vs. 7.7 %; p = 0.476) were numerically lower but did not reach statistical significance. Smoking cessation was threefold higher (25.0 % vs. 8.5 %; p = 0.026), pain declined significantly (median VAS 3 vs. 5; p < 0.001), and QALYs were higher (0.67 vs. 0.60; p < 0.001). No adverse events attributable to the program were recorded. Conclusions. The Chronic limb-threatening ischemia School significantly improved patient-reported outcomes and smoking cessation in patients with peripheral artery disease. Structured educational programs should be considered an integral component of comprehensive peripheral artery disease management.
- 1 January 2026
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 52 (2)
EFFECTIVENESS OF A MULTIMODAL PATIENT EDUCATION PROGRAM IN PATIENTS WITH AND WITHOUT TROPHIC ULCERS OF THE LOWER EXTREMITIES ASSOCIATED WITH PERIPHERAL ARTERY DISEASE
Relevance. Chronic limb-threatening ischemia is the most severe manifestation of peripheral artery disease, carrying high rates of amputation and mortality. Structured patient education programs have demonstrated benefit in other chronic diseases, yet remain largely unevaluated in peripheral artery disease, particularly chronic limb-threatening ischemia. Objective. To evaluate the effectiveness of a structured multimodal educational program (CLTI School) compared with standard care on clinical outcomes and quality of life in patients with peripheral artery disease. Materials and Methods. Parallel-group randomized controlled trial conducted in Astana, Kazakhstan. A total of 184 patients with peripheral artery disease (Rutherford categories 2-5) were randomized 1:1 and followed for 12 months. The program comprised eight vascular surgeon-led group sessions, a digital platform, peer support groups, and smoking cessation counseling. Per-protocol analysis included 81 experimental and 78 control participants. Co-primary outcomes were health-related quality of life (SF-12) and peripheral artery disease -related hospitalization rate. Results. At 12 months, the experimental group showed significantly higher SF-12 Physical Component Summary (44.76 vs. 35.08; p < 0.001) and Mental Component Summary (43.42 vs. 35.90; p < 0.001) scores. Hospitalizations (14.8 % vs. 20.5 %; p = 0.346) and amputations (4.9 % vs. 7.7 %; p = 0.476) were numerically lower but did not reach statistical significance. Smoking cessation was threefold higher (25.0 % vs. 8.5 %; p = 0.026), pain declined significantly (median VAS 3 vs. 5; p < 0.001), and QALYs were higher (0.67 vs. 0.60; p < 0.001). No adverse events attributable to the program were recorded. Conclusions. The Chronic limb-threatening ischemia School significantly improved patient-reported outcomes and smoking cessation in patients with peripheral artery disease. Structured educational programs should be considered an integral component of comprehensive peripheral artery disease management.
- Open Access
- 5 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1590401
Artificial intelligence–enhanced mapping of the international classification of functioning, disability and health via a mobile app: a randomized controlled trial
Background: Mobile health applications and artificial intelligence (AI) are increasingly utilized to streamline clinical workflows and support functional assessment. The International Classification of Functioning, Disability and Health (ICF) provides a standardized framework for evaluating patient functioning, yet AI-driven ICF mapping tools remain underexplored in routine clinical settings.Objective: This study aimed to evaluate the efficiency and accuracy of the MedQuest mobile application—featuring integrated AI-based ICF mapping—compared to traditional paper-based assessment in hospitalized patients.Methods: A parallel-group randomized controlled trial was conducted in two medical centers in Astana, Kazakhstan. A total of 185 adult inpatients (≥18 years) were randomized to either a control group using paper questionnaires or an experimental group using the MedQuest app. Both groups completed identical standardized assessments (SF-12, IPAQ, VAS, Barthel Index, MRC scale). The co-primary outcomes were (1) total questionnaire completion time and (2) agreement between AI-generated and clinician-generated ICF mappings, assessed using quadratic weighted kappa. Secondary outcomes included AI sensitivity/specificity, confusion matrix analysis, and physician usability ratings via the System Usability Scale (SUS).Results: The experimental group completed questionnaires significantly faster than the control group (median 18 vs. 28 min, p < 0.001). Agreement between AI- and clinician-generated ICF mappings was substantial (κ = 0.842), with 80.6% of qualifiers matching exactly. The AI demonstrated high sensitivity and specificity for common functional domains (e.g., codes 1–2), though performance decreased for rare qualifiers. The micro-averaged sensitivity and specificity were 0.806 and 0.952, respectively. Mean SUS score among physicians was 86.8, indicating excellent usability and acceptability.Conclusion: The MedQuest mobile application significantly improved workflow efficiency and demonstrated strong concordance between AI- and clinician-assigned ICF mappings. These findings support the feasibility of integrating AI-assisted tools into routine clinical documentation. A hybrid model, combining AI automation with clinician oversight, may enhance accuracy and reduce documentation burden in time-constrained healthcare environments.Trial registration: ClinicalTrials.gov, identifier NCT07021781.
- 5 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1590401
Open AccessArtificial intelligence–enhanced mapping of the international classification of functioning, disability and health via a mobile app: a randomized controlled trial
Background: Mobile health applications and artificial intelligence (AI) are increasingly utilized to streamline clinical workflows and support functional assessment. The International Classification of Functioning, Disability and Health (ICF) provides a standardized framework for evaluating patient functioning, yet AI-driven ICF mapping tools remain underexplored in routine clinical settings.Objective: This study aimed to evaluate the efficiency and accuracy of the MedQuest mobile application—featuring integrated AI-based ICF mapping—compared to traditional paper-based assessment in hospitalized patients.Methods: A parallel-group randomized controlled trial was conducted in two medical centers in Astana, Kazakhstan. A total of 185 adult inpatients (≥18 years) were randomized to either a control group using paper questionnaires or an experimental group using the MedQuest app. Both groups completed identical standardized assessments (SF-12, IPAQ, VAS, Barthel Index, MRC scale). The co-primary outcomes were (1) total questionnaire completion time and (2) agreement between AI-generated and clinician-generated ICF mappings, assessed using quadratic weighted kappa. Secondary outcomes included AI sensitivity/specificity, confusion matrix analysis, and physician usability ratings via the System Usability Scale (SUS).Results: The experimental group completed questionnaires significantly faster than the control group (median 18 vs. 28 min, p < 0.001). Agreement between AI- and clinician-generated ICF mappings was substantial (κ = 0.842), with 80.6% of qualifiers matching exactly. The AI demonstrated high sensitivity and specificity for common functional domains (e.g., codes 1–2), though performance decreased for rare qualifiers. The micro-averaged sensitivity and specificity were 0.806 and 0.952, respectively. Mean SUS score among physicians was 86.8, indicating excellent usability and acceptability.Conclusion: The MedQuest mobile application significantly improved workflow efficiency and demonstrated strong concordance between AI- and clinician-assigned ICF mappings. These findings support the feasibility of integrating AI-assisted tools into routine clinical documentation. A hybrid model, combining AI automation with clinician oversight, may enhance accuracy and reduce documentation burden in time-constrained healthcare environments.Trial registration: ClinicalTrials.gov, identifier NCT07021781.
- Open Access
- 30 June 2025
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 125 (3) , amj003
Organization of complex rehabilitation of patients with long non-healing trophic ulcers of the lower extremities: Literature review
Chronic non-healing trophic ulcers of the lower extremities remain a pressing issue in modern medicine. According to epidemiological studies, 1–2% of the adult population in developed countries suffers from chronic leg ulcers, with prevalence increasing to 4–5% among individuals over 65 years old. Current treatment protocols often focus on isolated aspects of the pathological process, neglecting the necessity of a comprehensive rehabilitation approach. The management of such patients requires the implementation of a three-stage rehabilitation system ensuring continuity between inpatient and outpatient care.Systematization of modern rehabilitation approaches enables the recommendation of individualized rehabilitation programs that consider both medical and psychosocial aspects of the disease. Such an approach enhances treatment effectiveness and improves patients’ quality of life. The development of an effective social support system that ensures access to necessary resources and services is a crucial task in organizing care for this patient population.Keywords:foot ulcer, rehabilitation, peripheral artery disease, quality of life, interdisciplinary communication, patient care planning, disease management.
- 30 June 2025
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 125 (3) , amj003
Open AccessOrganization of complex rehabilitation of patients with long non-healing trophic ulcers of the lower extremities: Literature review
Chronic non-healing trophic ulcers of the lower extremities remain a pressing issue in modern medicine. According to epidemiological studies, 1–2% of the adult population in developed countries suffers from chronic leg ulcers, with prevalence increasing to 4–5% among individuals over 65 years old. Current treatment protocols often focus on isolated aspects of the pathological process, neglecting the necessity of a comprehensive rehabilitation approach. The management of such patients requires the implementation of a three-stage rehabilitation system ensuring continuity between inpatient and outpatient care.Systematization of modern rehabilitation approaches enables the recommendation of individualized rehabilitation programs that consider both medical and psychosocial aspects of the disease. Such an approach enhances treatment effectiveness and improves patients’ quality of life. The development of an effective social support system that ensures access to necessary resources and services is a crucial task in organizing care for this patient population.Keywords:foot ulcer, rehabilitation, peripheral artery disease, quality of life, interdisciplinary communication, patient care planning, disease management.